Pro Medicus Limited (PME.AX)
Makes software that lets doctors view and manage medical images across hospitals worldwide.
162.68-0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-48.2%
The outlook
PME.AX is trading below both its 50- and 200-day moving averages, sitting in the lower quarter of its 52-week range. Analyst consensus leans toward Buy, with an average price target about 17% above the current level, though the stock carries a notably elevated trailing P/E of 72.6. Overall sentiment is neutral, balancing the positive analyst view against the weak near-term technical position.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 15 analysts
Price trendBelow its 50- & 200-day averages
52-week range25% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 15 analysts190.34average target+17.0% vs now
Now 162.68
Low 54.00High 250.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$17.00B
52-wk high
324.49
52-wk low
107.75
50-day avg
171.95
200-day avg
179.49
Trailing P/E
72.6